An Open-Label, Single-Dose, Pharmacokinetic Study of EXE844 Sterile Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery

Trial Profile

An Open-Label, Single-Dose, Pharmacokinetic Study of EXE844 Sterile Otic Suspension, 0.3% in Pediatric Subjects Following Tympanostomy Tube Surgery

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2016

At a glance

  • Drugs Finafloxacin (Primary)
  • Indications Otitis media
  • Focus Pharmacokinetics
  • Sponsors Alcon
  • Most Recent Events

    • 19 May 2016 Status changed from recruiting to completed.
    • 06 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 May 2016, as reported by ClinicalTrials.gov record.
    • 06 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 May 2016, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top